| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004104020A3 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 04/28/2005 | WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2) |
| 04/28/2005 | WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto |
| 04/28/2005 | WO2004096832A3 Novel antiangiogenic peptides |
| 04/28/2005 | WO2004090135A3 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 04/28/2005 | WO2004089279A3 Long-acting derivatives of pyy agonists |
| 04/28/2005 | WO2004073630A3 Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
| 04/28/2005 | WO2004064759A3 Use of tryptanthrin compounds for immune potentiation |
| 04/28/2005 | WO2004063329A3 Modulation of pten expression via oligomeric compounds |
| 04/28/2005 | WO2004062587A3 Night-time oral insulin therapy |
| 04/28/2005 | WO2004050833A3 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 04/28/2005 | WO2004047750A3 Modulation of notch2 expression |
| 04/28/2005 | WO2004044160A3 Muc1 interference rna compositions and methods derived therefrom |
| 04/28/2005 | WO2004041846A3 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 04/28/2005 | WO2004033631A8 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/28/2005 | WO2004032878A3 Compositions, organisms and methodologies employing a novel human kinase |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/28/2005 | WO2004020583A8 Polynucleotide predictor set for identifying protein tyrosine kinase modulators |
| 04/28/2005 | WO2004011620A3 Methods and compositions using polynucleotides and polypeptides of rank-associated inhibitor (rain) |
| 04/28/2005 | WO2003099227A3 Modulation of ptp1b signal transduction by rna interference |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003093419A3 Preventing secondary lymphedema with vegf-d dna |
| 04/28/2005 | WO2003092631A3 Cyclic peptide anti-viral agents and methods |
| 04/28/2005 | WO2003084987A3 Polypeptides from bacteria and uses thereof |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2002092768A3 Novel alanine transaminase enzyme and methods of use |
| 04/28/2005 | US20050091713 Nucleic acid nematicides |
| 04/28/2005 | US20050090891 Stent lining |
| 04/28/2005 | US20050090693 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/28/2005 | US20050090657 Novel human proteases and polynucleotides encoding the same |
| 04/28/2005 | US20050090656 Cloning, sequencing and expresssion of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090643 protein isolated from cyanobacteria, is known to have anti-viral activity |
| 04/28/2005 | US20050090520 Treatment of disease or injury of the nervous system with FTY720 |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090474 Methods and compositions for enhancing and inhibiting fertilization |
| 04/28/2005 | US20050090466 Inhibitors of PACE4 for the treatment of arthritis |
| 04/28/2005 | US20050090465 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 04/28/2005 | US20050090464 Vectors for enhanced expression of Vegf for disease treatment |
| 04/28/2005 | US20050090451 Treatment of cancer with glutamine |
| 04/28/2005 | US20050090450 enzyme inhibitors such as Pyrazine-2-carboxylic acid (cyclohexyl-{1-[2-(1-cyclopropylaminooxalyl-butylcarbamoyl)-3-isopropyl-pyrrolidine-1-carbonyl]-2,2-dimethyl-propylcarbamoyl}-methyl)-amide, used for treating viral diseases or pretreatment of medical equipment |
| 04/28/2005 | US20050090449 treating neurodegenerative diseases by administering drugs that inhibit beta-secretase-mediated cleavage of amyloid precursor proteins |
| 04/28/2005 | US20050090448 Peptides that inhibit complement activation |
| 04/28/2005 | US20050090447 Peptides that promote complement activation |
| 04/28/2005 | US20050090446 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 04/28/2005 | US20050090445 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/28/2005 | US20050090444 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 04/28/2005 | US20050090443 Biosynthesis inhibition of oestrogen in an oestrogen-dependent breast tumor by administering a antitumor biodrug, Sant 7; aromatase, oestrone sulphatase, or oestradiol dehydrogenase inhibitors |
| 04/28/2005 | US20050090442 administering peptides, polypeptides, proteins or mimetics which correspond to non-membrane associated form of the p75 neurotrophin receptor (p75NTR) death signal region; antiapoptosis |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090440 Tumour treating combinations, compositions and methods |
| 04/28/2005 | US20050090438 Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders |
| 04/28/2005 | US20050090436 Human tumor necrosis factor receptors TR21 and TR22 |
| 04/28/2005 | US20050090433 Dalbavancin compositions for treatment of bacterial infections |
| 04/28/2005 | US20050090432 Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus |
| 04/28/2005 | US20050090431 Water soluble prodrugs of hindered alcohols |
| 04/28/2005 | US20050090430 treating hemachromatosis comprising administering an HFE polypeptide, fragments, or a complex with beta -2-microglobulin; genetic disorders |
| 04/28/2005 | US20050090429 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 04/28/2005 | US20050090427 Delivery of drugs to the bloodstream in toothpaste |
| 04/28/2005 | US20050090426 in mammals by administering drugs which inhibits the expression or activity of microsomal triglyceride transfer proteins; antiinflammatory agents; enzyme inhibitors |
| 04/28/2005 | US20050090424 Administering concurrent with cell grafting surgery using insulin producing stem cells |
| 04/28/2005 | US20050090007 To produce human proteins in economical yields and in a form which is suitable for the production of a pharmaceutical preparation |
| 04/28/2005 | US20050090000 Novel human 7TM protein and polynucleotides encoding the same |
| 04/28/2005 | US20050089999 Method for the production and purification of adenoviral vectors |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089969 exsulins have a molecular weight of up to 55,000 Daltons and have1 to 50 basic units of specific amino acids; therapeutic and dietetic use |
| 04/28/2005 | US20050089959 Protoxins, cytotoxins; antibodies; cleavage via trypsin; for lysing human cancer cells |
| 04/28/2005 | US20050089958 Cytokines which induce mammalian cell apoptosis; tumor necrosis factors; cancer, gliomas |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089929 Binding native human tissue factor (TF) and does not substantially bind non-native tissue factor; superior anticoagulant activity by binding with high affinity and specificity; reducing cancer cell tissue factor activity and detecting cancer cells that express TF; factor X binding is inhibited |
| 04/28/2005 | US20050089925 43239, a novel GPCR-like molecule and uses thereof |
| 04/28/2005 | US20050089921 Controlling cell proliferative using polypeptides; antitumor, anticancer agents |
| 04/28/2005 | US20050089917 Novel kinases and uses thereof |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089907 Nucleotide sequences coding enzymatic polypeptide for use in pharmacology and human therapeutics and diagnostics |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089896 Method to control tumor progression and invasiveness |
| 04/28/2005 | US20050089892 Biiodrugs for diagnosis, drug screening, clinical trial monitoring, treatment of physiological disorders; viral disease and infection prevention; expression vectors |
| 04/28/2005 | US20050089888 Platelet glycoprotein Ib alpha variant fusion polypeptides and methods of use thereof |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089869 GlcNac phosphotransferase of the lysosomal targeting pathway |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089866 Identifying modulators for the treatment and prevention of diabetes, pain, obesity, nervous system, inflammatory, cell proliferative and liver disorders |
| 04/28/2005 | US20050089858 Expression vector comprising nucleotide sequences coding tumor suppressor protein for use in diagnosis and prevention of cell proliferative disorders |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089844 Novel dual oxidases as mitogenic and endocrine regulators |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
| 04/28/2005 | US20050089840 Peptide derivative fusion inhibitors of HIV infection |
| 04/28/2005 | US20050089588 Dietary supplements containing natural ingredients |
| 04/28/2005 | US20050089579 For therapy of bone disorders |
| 04/28/2005 | US20050089552 Silk fibroin fiber bundles for matrices in tissue engineering |
| 04/28/2005 | US20050089547 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/28/2005 | US20050089546 Compositions and methods comprising complex carbohydrate and alpha-lactalbumin |